1. Home
  2. HWKN vs NRIX Comparison

HWKN vs NRIX Comparison

Compare HWKN & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$130.45

Market Cap

2.7B

ML Signal

HOLD

NRIX

Nurix Therapeutics Inc.

SELL

Current Price

$22.14

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HWKN
NRIX
Founded
1938
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
HWKN
NRIX
Price
$130.45
$22.14
Analyst Decision
Buy
Buy
Analyst Count
3
14
Target Price
★ $174.25
$33.93
AVG Volume (30 Days)
146.6K
★ 1.4M
Earning Date
10-26-2026
10-23-2026
Dividend Yield
★ 0.62%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.35
N/A
Revenue
★ $1,083,696,000.00
$76,987,000.00
Revenue This Year
$7.95
$799.42
Revenue Next Year
$7.46
N/A
P/E Ratio
$96.69
★ N/A
Revenue Growth
11.21
★ 99.31
52 Week Low
$116.05
$9.14
52 Week High
$176.58
$28.23

Technical Indicators

Market Signals
Indicator
HWKN
NRIX
Relative Strength Index (RSI) 55.88 31.71
Support Level $130.08 $21.23
Resistance Level $130.52 $24.65
Average True Range (ATR) 3.37 0.96
MACD 0.49 -0.14
Stochastic Oscillator 69.40 21.25

Price Performance

Historical Comparison
HWKN
NRIX

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The Industrial Solutions segment, provides industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. The water treatment segment, which generates the majority of revenue sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Food and Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: